Gebrehiwet, P., Meng, L., Rudnicki, S. A., Sarocco, P., Wei, J., Wolff, A. A., Butzner, M., Chiò, A., Andrews, J. A., Genge, A., Hughes, D. A., Jackson, C. E., Lechtzin, N., Miller, T. M., & Shefner, J. M. (2023). Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS. Journal of Medical Economics, 26(1), 488–493. https://doi.org/10.1080/13696998.2023.2192588